Using Selling Simulator For New Drug Launch In The New Normal

The reverberation of unparalleled business disruptions in healthcare caused by Covid pandemic, extends across its value chain – from patients and families to clinicians and pharmaceutical companies. Consequently, even many diehards or staunchly tradition-bound pharma marketers were being prompted to reimagine their … Continue reading

Leverage AI For Competitive Edge With Omnichannel Pharma Marketing

With the requirements of strict compliance to ‘Covid appropriate behavior’ becoming critical for all, pharma reps’ physical access to physicians for F2F calls got severely restricted, across the world. A paper from IQVIA of May 14, 2021, reported: ‘As patient visits shifted … Continue reading

Appears On Radar New L&D Needs For Pharma’s New e-Environment

As drug companies were desperately trying to navigate through the operational disruptions due to Covid crisis, the Learning and Development (LD) plans of most organizations, considered so important for employees, got badly impacted. This was ably captured in the article … Continue reading

Fostering EQ For Pharma’s Excellence In The New Normal

On February 25, 2021, one of the top Indian business daily flashed a headline – “It will be working from home, post-pandemic too at many top companies.” It wrote, companies like, Tata Steel, Philips, Infosys and Maruti Suzuki are evaluating job roles to … Continue reading

Covid Propels Healthcare Into A Virtual World: A New Growth Driver For Pharma?

Amid ongoing Covid pandemic, most discussions on pharma specific ‘digitalization’ initiatives continue to predominantly hover around its traditional business growth drivers. In fact, even before the Covid time, it was no different, in a smaller scale and with a lesser … Continue reading